2026 ICD-10-CM Diagnosis Code Q79.69Other Ehlers-Danlos syndromes
ICD-10-CM Codes›Q00-Q99›Q65-Q79›Q79
- Billable — Valid for Submission
- POA Exempt
- Chronic Condition
Q79.69 is a billable ICD-10-CM diagnosis code for other Ehlers-Danlos syndromes. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 564 through 566. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Musculoskeletal congenital conditions.
Code Identity
Code Classification
Present on Admission (POA)Billing
Q79.69 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Arthrochalasia Ehlers-Danlos syndrome
- B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome
- Brittle cornea syndrome
- Classical-like Ehlers-Danlos syndrome type 1
- Classical-like Ehlers-Danlos syndrome type 2
- Congenital kyphoscoliosis
- Congenital kyphosis
- Corneal thinning
- Cutis laxa, x-linked
- Dermatosparaxis Ehlers-Danlos syndrome
- Disorder of copper metabolism
- Ehlers-Danlos syndrome cardiac valvular type
- Ehlers-Danlos syndrome kyphoscoliotic and deafness type
- Ehlers-Danlos syndrome kyphoscoliotic type
- Ehlers-Danlos syndrome musculocontractural type
- Ehlers-Danlos syndrome progeroid type
- Ehlers-Danlos syndrome spondylocheirodysplastic type
- Ehlers-Danlos syndrome, dysfibronectinemic
- Ehlers-Danlos syndrome, hydroxylysine-deficient
- Familial articular hypermobility syndrome
- Myopathic Ehlers-Danlos syndrome
- Periodontal Ehlers-Danlos syndrome
- Periodontitis co-occurrent with genetic disorder
- Spondylodysplastic Ehlers-Danlos syndrome
- X-linked Ehlers-Danlos syndrome
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Meekeren-Ehlers-Danlos syndrome - See Also: Syndrome, Ehlers-Danlos; - Q79.69
- Syndrome - See Also: Disease;
- Ehlers-Danlos - Q79.60
- specified NEC - Q79.69
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Meekeren-Ehlers-Danlos syndrome
- Syndrome
- Ehlers-Danlos
- specified NEC
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Corneal Thinning
progressive deformation of the corneal structure, characterized by thinning of the cornea.Congenital Kyphosis
an abnormally increased curvature of the thoracic portion of the spine that is present at the time of birth.
Patient EducationClinical
Ehlers-Danlos Syndrome
Ehlers-Danlos syndrome (EDS) is a group of inherited disorders that weaken connective tissues. Connective tissues are proteins that support skin, bones, blood vessels, and other organs.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Code History & ChangesHistory
Replacement Q79.69 replaces the following previously assigned code(s):
- Q79.6 - Ehlers-Danlos syndrome
- Q79.6 - Ehlers-Danlos syndromes
Questions About Q79.69Overview
Is Q79.69 (Ehlers-Danlos syndromes) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report other Ehlers-Danlos syndromes on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does Q79.69 group to?
When other Ehlers-Danlos syndromes is the principal diagnosis on an inpatient stay, it groups to MS-DRG 564, 565, 566, with relative weights from 0.7493 to 1.5436 depending on complications. Higher weights mean higher Medicare reimbursement.
Is Q79.69 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for other Ehlers-Danlos syndromes on inpatient claims.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
